70024-40-7 | Terazosin hydrochloride dihydrate

Packsize	Purity	Availability	Price	Discounted Price
25mg	98%	in stock	$15.00	$10.00
100mg	98%	in stock	$18.00	$12.00
1g	98%	in stock	$22.00	$15.00
5g	98%	in stock	$52.00	$36.00
10g	98%	in stock	$83.00	$58.00
25g	98%	in stock	$170.00	$119.00
100g	98%	in stock	$493.00	$345.00

Description

• Catalog Number: AB56546
• Chemical Name: Terazosin hydrochloride dihydrate
• CAS Number: 70024-40-7
• Molecular Formula: C19H30ClN5O6
• Molecular Weight: 459.9244
• MDL Number: MFCD00941408
• SMILES: COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)C1CCCO1.Cl.O.O

Computed Properties

• Complexity: 544
• Covalently-Bonded Unit Count: 4
• Heavy Atom Count: 31
• Hydrogen Bond Acceptor Count: 10
• Hydrogen Bond Donor Count: 4
• Rotatable Bond Count: 4
• Undefined Atom Stereocenter Count: 1

Literature

• Effect of global and regional sympathetic blockade on arterial pressure during water deprivation in conscious rats.

  American journal of physiology. Heart and circulatory physiology 20121015

• A new experimental design method to optimize formulations focusing on a lubricant for hydrophilic matrix tablets.

  Drug development and industrial pharmacy 20120901

• Identification and profiling of novel α1A-adrenoceptor-CXC chemokine receptor 2 heteromer.

  The Journal of biological chemistry 20120413

• Revelation on the potency of α(1) -blockers - parallel blockade of angiotensin II receptor: a new finding.

  Pharmaceutical biology 20120401

• Prescriber monitoring for benign prostatic hyperplasia within a family medicine clinic: a comparison of medication classes.

  Journal of pharmacy practice 20120401

• Cocaine self-administration is not dependent upon mesocortical α1 noradrenergic signaling.

  Neuroreport 20120328

• Structural characteristics of renal glomerular system in ISIAH rats under conditions of chronic stress and preventive hypotensive drug therapy.

  Bulletin of experimental biology and medicine 20111201

• Pharmacologic pupil dilation as a predictive test for the risk for intraoperative floppy-iris syndrome.

  Journal of cataract and refractive surgery 20110801

• Cell membrane chromatography competitive binding analysis for characterization of α1A adrenoreceptor binding interactions.

  Analytical and bioanalytical chemistry 20110701

• Comparison of effects of alpha receptor blockers on endothelial functions and coagulation parameters in patients with benign prostatic hyperplasia.

  Urology 20110601

• A novel three-layered tablet for extended release with various layer formulations and in vitro release profiles.

  Drug development and industrial pharmacy 20110601

• Time-oriented experimental design method to optimize hydrophilic matrix formulations with gelation kinetics and drug release profiles.

  International journal of pharmaceutics 20110404

• Risk factors for intraoperative floppy iris syndrome: a meta-analysis.

  Ophthalmology 20110401

• Norepinephrine antagonists and cancer risk.

  International journal of cancer 20110201

• [How effective is finasteride?].

  Deutsche medizinische Wochenschrift (1946) 20110201

• Arylpiperazines for management of benign prostatic hyperplasia: design, synthesis, quantitative structure-activity relationships, and pharmacokinetic studies.

  Journal of medicinal chemistry 20110113

• Efficacy of three different alpha 1-adrenergic blockers and hyoscine N-butylbromide for distal ureteral stones.

  International braz j urol : official journal of the Brazilian Society of Urology 20110101

• Effect of terazosin on lower urinary tract symptoms and pain due to double-J stent: a double-blind placebo-controlled randomized clinical trial.

  Urologia internationalis 20110101

• Identification of a novel form of noradrenergic-dependent respiratory motor plasticity triggered by vagal feedback.

  The Journal of neuroscience : the official journal of the Society for Neuroscience 20101215

• Ventral striatal noradrenergic mechanisms contribute to sensorimotor gating deficits induced by amphetamine.

  Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20101101

• Antagonism of lateral amygdala alpha1-adrenergic receptors facilitates fear conditioning and long-term potentiation.

  Learning & memory (Cold Spring Harbor, N.Y.) 20101001

• A pharma-robust design method to investigate the effect of PEG and PEO on matrix tablets.

  International journal of pharmaceutics 20100630

• Development and validation of an Arabic version of the International Prostate Symptom Score.

  BJU international 20100501

• Investigating contamination of phytotherapy products for benign prostatic hyperplasia with alpha-blockers and 5alpha-reductase inhibitors.

  The Journal of urology 20100501

• Primary bladder neck dysfunction in children and adolescents III: results of long-term alpha-blocker therapy.

  The Journal of urology 20100201

• Symptomatic comparison in efficacy on patients with benign prostatic hyperplasia treated with two therapeutic approaches.

  Complementary therapies in medicine 20100201

• Alpha-1 adrenoceptor stimulation triggers axon-reflex vasodilatation in human skin.

  Autonomic neuroscience : basic & clinical 20091203

• Amlodipine alone or combined with terazosin improves lower urinary tract disorder in rat models of benign prostatic hyperplasia or detrusor instability: focus on detrusor overactivity.

  BJU international 20091201

• Role of alpha adrenergic blocker in the management of posterior urethral valves.

  Pediatric surgery international 20091201

• A round table discussion: case studies of patients with lower urinary tract symptoms.

  The Urologic clinics of North America 20091101

• Buthus tamulus venom-induced vasosensory reflexes are mediated through efferent pathways in sympathetic and vagal parasympathetics.

  Neuroscience letters 20091030

• Fluorescent quantification of terazosin hydrochloride content in human plasma and tablets using second-order calibration based on both parallel factor analysis and alternating penalty trilinear decomposition.

  Analytica chimica acta 20090914

• [Dexketoprofen trometamol in the treatment of chronic prostatitis/chronic pelvic pain syndrome].

  Zhonghua nan ke xue = National journal of andrology 20090901

• Effects of four different alpha(1)-adrenoceptor antagonists on alpha-adrenoceptor agonist-induced contractions in isolated mouse and hamster ureters.

  Journal of smooth muscle research = Nihon Heikatsukin Gakkai kikanshi 20090801

• [Retrospective analysis of the combined therapy of terazosin with chlormezanone for chronic prostatitis/chronic pelvic pain syndrome].

  Zhonghua nan ke xue = National journal of andrology 20090801

• Tamsulosin versus terazosin for benign prostatic hyperplasia: a systematic review.

  Systems biology in reproductive medicine 20090801

• Direct high-performance liquid chromatography enantioseparation of terazosin on an immobilised polysaccharide-based chiral stationary phase under polar organic and reversed-phase conditions.

  Journal of chromatography. A 20090710

• A multicomponent behavioural and drug intervention for nocturia in elderly men: rationale and pilot results.

  BJU international 20090701

• Efficacy of combined amlodipine/terazosin therapy in male hypertensive patients with lower urinary tract symptoms: a randomized, double-blind clinical trial.

  Urology 20090701

• Iris morphologic changes related to alpha(1)-adrenergic receptor antagonists implications for intraoperative floppy iris syndrome.

  Ophthalmology 20090501

• [Amlodipine combined with terazosin reduces postvoid residual and the risk of acute urinary retention].

  Zhonghua nan ke xue = National journal of andrology 20090501

• Combined effects of terazosin and genistein on a metastatic, hormone-independent human prostate cancer cell line.

  Cancer letters 20090408

• alpha(1)-Adrenoceptors augment thermal hyperalgesia in mildly burnt skin.

  European journal of pain (London, England) 20090301

• Alpha-blocker plus diuretic combination therapy as second-line treatment for nocturia in men with LUTS: a pilot study.

  Urology 20090301

• Functional screening of adrenergic receptors by measuring intracellular calcium using the FlexStation scanning fluorimeter.

  Biotechnology journal 20090301

• Terazosin treatment suppresses basic fibroblast growth factor expression in the rat ventral prostate.

  Clinical and investigative medicine. Medecine clinique et experimentale 20090201

• Adjunctive medical therapy with an alpha-1A-specific blocker after shock wave lithotripsy of lower ureteral stones.

  Urologia internationalis 20090101

• [Using setegis (terasosine) in early postoperative period after transurethral prostate resection].

  Urologiia (Moscow, Russia : 1999) 20090101

• Effects of alpha-adrenoceptor antagonist doxazosin on MDR1-mediated multidrug resistance and transcellular transport.

  Oncology research 20090101

• Efficacy of alpha-Adrenergic Receptor Blockers in the Treatment of Male Lower Urinary Tract Symptoms.

  Reviews in urology 20090101

• Noradrenaline triggers muscle tone by amplifying glutamate-driven excitation of somatic motoneurones in anaesthetized rats.

  The Journal of physiology 20081201

• [Efficacy of electroacupuncture in treating 93 patients with benign prostatic hyperplasia].

  Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese journal of integrated traditional and Western medicine 20081101

• Fabrication of terazocin-loaded poly(D,L-lactide) microspheres by an ultrasonic spray drying method and their release behaviors.

  Journal of nanoscience and nanotechnology 20081001

• Combined use of melatonin and terazosin restores bladder contractility in rabbits with partial outlet obstruction.

  Urology 20080801

• Effect of duloxetine, a norepinephrine and serotonin reuptake inhibitor, on sneeze-induced urethral continence reflex in rats.

  American journal of physiology. Renal physiology 20080701

• Intraoperative floppy-iris syndrome associated with systemic alpha blockers.

  Journal of cataract and refractive surgery 20080701

• Impacts of the quinazoline-based alpha1-antagonist, terazosin, and of the sulfonamide derivative, tamsulosin, on serum prostate-specific antigen and prostate volume.

  Journal of Korean medical science 20080601

• [Alpha blockers in use for symptomatic benign prostatic hyperplasia--are all drugs born equal?].

  Harefuah 20080601

• Endogenous melanocortin system activity contributes to the elevated arterial pressure in spontaneously hypertensive rats.

  Hypertension (Dallas, Tex. : 1979) 20080401

• Terazosin therapy for patients with female lower urinary tract symptoms: a randomized, double-blind, placebo controlled trial.

  The Journal of urology 20080401

• Acute generalized exanthematous pustulosis caused by terazosin hydrochloride.

  Journal of drugs in dermatology : JDD 20080401

• Effect of peripheral sympathetic nerve dysfunction on salt sensitivity of arterial pressure.

  Clinical and experimental pharmacology & physiology 20080301

• FPIN's clinical inquiries. Medical treatment of benign prostatic hyperplasia.

  American family physician 20080301

• Lichenoid drug eruption to terazosin.

  The British journal of dermatology 20080201

• alpha(1)-Adrenoceptor antagonists prevent paracetamol-induced hepatotoxicity in mice.

  British journal of pharmacology 20080201

• Comparison of cystometric methods in female rats.

  Neurourology and urodynamics 20080101

• Comparing the therapeutic outcome of different alpha-blocker treatments for BPH in the same individuals.

  International urology and nephrology 20080101

• Acute intoxication with terazosin.

  The American journal of emergency medicine 20080101

• Pharmacokinetic and pharmacodynamic modelling of arterial haemodynamic effects of terazosin in healthy volunteers.

  Clinical drug investigation 20080101

• Efficacy of an alpha1 blocker in expulsive therapy of lower ureteral stones.

  Journal of endourology 20080101

• High-dose terazosin therapy (5mg) in Korean patients with lower urinary tract symptoms with or without concomitant hypertension: a prospective, open-label study.

  Yonsei medical journal 20071231

• Human epididymal and prostatic tracts of vas deferens: different contraction response to noradrenaline stimulation in isolated organ bath assay.

  European journal of pharmacology 20071222

• [Efficacy of monotherapy with 15 antihypertensive agents in treating essential hypertension assessed by 24-hour ambulatory blood pressure monitoring].

  Zhongguo yi xue ke xue yuan xue bao. Acta Academiae Medicinae Sinicae 20071201

• New-onset priapism associated with ingestion of terazosin in an otherwise healthy man.

  The journal of sexual medicine 20071101

• Effect of alpha1-adrenoceptor antagonist exposure on prostate cancer incidence: an observational cohort study.

  The Journal of urology 20071101

• A rapid and simple high-performance liquid chromatography method for the determination of human plasma levofloxacin concentration and its application to bioequivalence studies.

  Biomedical chromatography : BMC 20071001

• [Progress in the studies of alpha1-adrenoceptor blocker for concurrent benign prostatic hyperplasia and hypertension].

  Zhonghua nan ke xue = National journal of andrology 20070901

• Determination of adenosine effects and adenosine receptors in murine corpus cavernosum.

  The Journal of pharmacology and experimental therapeutics 20070801

• [Comparison of different drugs on the treatment of benign prostate hyperplasia].

  Zhonghua wai ke za zhi [Chinese journal of surgery] 20070715

• Prediction of alpha1-adrenoceptor occupancy in the human prostate from plasma concentrations of silodosin, tamsulosin and terazosin to treat urinary obstruction in benign prostatic hyperplasia.

  Biological & pharmaceutical bulletin 20070701

• Delayed effects of hypotensive drugs on structural characteristics of the renal glomerular system in hypertensive NISAG rats.

  Bulletin of experimental biology and medicine 20070601

• Pharmacokinetic and pharmacodynamic consequences of inhibition of terazosin metabolism via CYP3A1 and/or 3A2 by DA-8159, an erectogenic, in rats.

  British journal of pharmacology 20070501

• Role of alpha(1)-adrenoceptors of the locus coeruleus in self-stimulation of the medial forebrain bundle.

  Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20070401

• Effects of branded versus generic terazosin hydrochloride in adults with benign prostatic hyperplasia: a randomized, open-label, crossover study in Taiwan.

  Clinical therapeutics 20070401

• Efficacy and safety of combined therapy with terazosin and tolteradine for patients with lower urinary tract symptoms associated with benign prostatic hyperplasia: a prospective study.

  Chinese medical journal 20070305

• The effects of systemic alpha-1 adrenergic antagonists on pupil diameter in rats.

  Current eye research 20070301

• Terazosin modifies the content of glycosaminoglycans and the activity of matrix metalloproteinase 2 in the rat ventral prostate.

  European urology 20070201

• [An open randomized comparative trial of efficacy and safety of selective alpha-adrenoblocker setegis (terazosin) in therapy of patients with chronic bacterial prostatitis].

  Urologiia (Moscow, Russia : 1999) 20070101

• Zolpidem pharmacotherapy combined with alpha-blocker therapy for nocturia unresponsive to alpha-blocker monotherapy in men with lower urinary tract symptoms: a preliminary study.

  International urology and nephrology 20070101

• Intraoperative floppy iris syndrome associated with terazosin.

  Indian journal of ophthalmology 20070101

• [Efficacy of setegis administration after transvesical adenomectomy].

  Urologiia (Moscow, Russia : 1999) 20070101

• Cardio-protective role of terazosin is possibly mediated through alteration in thyroid function.

  European journal of pharmacology 20061203

• Endogenous excitatory drive modulating respiratory muscle activity across sleep-wake states.

  American journal of respiratory and critical care medicine 20061201

• The effect of terazosin on functional bladder outlet obstruction in women: a pilot study.

  The Journal of urology 20061001

• alpha-blocker treatment of urolithiasis.

  European urology 20060801

• Efficacy of terazosin as a facilitator agent for expulsion of the lower ureteral stones.

  Saudi medical journal 20060601

• alpha-blocker monotherapy in the treatment of nocturia in men with lower urinary tract symptoms: a prospective study of response prediction.

  BJU international 20060501

• Significance of nocturnal hesitancy in treatment of men with lower urinary tract symptoms.

  Urology 20060501

• Role of CNS alpha1-adrenoceptor activity in central fos responses to novelty.

  Synapse (New York, N.Y.) 20060401

• Identification, preparation, and characterization of several polymorphs and solvates of terazosin hydrochloride.

  Journal of pharmaceutical sciences 20060401

• Treatment and pharmacologic management of BPH in the context of common comorbidities.

  The American journal of managed care 20060401

• In vivo studies on the effects of alpha1-adrenoceptor antagonists on pupil diameter and urethral tone in rabbits.

  Naunyn-Schmiedeberg's archives of pharmacology 20060201

• More effects of extracorporeal magnetic innervation and terazosin therapy than terazosin therapy alone for non-inflammatory chronic pelvic pain syndrome: a pilot study.

  Prostate cancer and prostatic diseases 20060101

• Pharmacologic expulsive treatment of ureteral calculi.

  The Annals of pharmacotherapy 20060101

• [Using terasosine (setegis) in the treatment of hyperactive urinary bladder in elderly women].

  Urologiia (Moscow, Russia : 1999) 20060101

• Alpha1-adrenergic antagonists and floppy iris syndrome: tip of the iceberg?

  Ophthalmology 20051201

• Alpha(1)-adrenergic and alpha(2)-adrenergic balance in the dorsal pons and gross behavioral activity of mice in a novel environment.

  Psychopharmacology 20051101

• Effects of different alpha-1 adrenoceptor blockers on proximal urethral function using in vivo isovolumetric pressure changes.

  Journal of smooth muscle research = Nihon Heikatsukin Gakkai kikanshi 20051001

• Efficacy of terazosin and finasteride in symptomatic benign prostatic hyperplasia: A comparative study.

  Bangladesh Medical Research Council bulletin 20050801

• Initial, long-term, and durable responses to terazosin, placebo, or other therapies for chronic prostatitis/chronic pelvic pain syndrome.

  Urology 20050701

• The risk of overanticoagulation with antibiotic use in outpatients on stable warfarin regimens.

  Journal of general internal medicine 20050701

• Evidence of roles of central alpha1-adrenoceptors and epinephrine in orexin A-induced hyperactivity in mice.

  Neuroscience letters 20050624

• The comparison and efficacy of 3 different alpha1-adrenergic blockers for distal ureteral stones.

  The Journal of urology 20050601

• Effect of terazosin on tissue vascularity and apoptosis in transitional cell carcinoma of bladder.

  Urology 20050501

• High prevalence of orthostatic hypotension and its correlation with potentially causative medications among elderly veterans.

  Journal of clinical pharmacy and therapeutics 20050401

• Comparative evaluation of Prostina and terazosin in the treatment of benign prostatic hyperplasia.

  Journal of the Indian Medical Association 20050201

• Sympathetic modulation of activity in Adelta- and C-primary nociceptive afferents after intradermal injection of capsaicin in rats.

  Journal of neurophysiology 20050101

• alpha1-Adrenergic receptor antagonists induce production of IL-18 and expression of ICAM-1 and CD40 in human monocytes.

  Journal of immunotherapy (Hagerstown, Md. : 1997) 20050101

• [Double-blind placebo-controlled trial of terazosine efficacy in patients with chronic abacterial prostatitis].

  Urologiia (Moscow, Russia : 1999) 20050101

• [Clinical efficacy and safety of terazosine (setegis) in patients with benign prostatic hyperplasia with concomitant cardiovascular diseases].

  Urologiia (Moscow, Russia : 1999) 20050101

• [Kornam in the treatment of imperative urine incontinence in females].

  Urologiia (Moscow, Russia : 1999) 20050101

• Terazosin in the treatment of premature ejaculation: a short-term follow-up.

  International urology and nephrology 20050101

• Sympathetic and angiotensin-dependent hypertension during cage-switch stress in mice.

  American journal of physiology. Regulatory, integrative and comparative physiology 20041201

• Role of locus coeruleus alpha1-adrenoceptors in motor activity in rats.

  Synapse (New York, N.Y.) 20041201

• Visceral afferent bias on cortical processing: role of adrenergic afferents to the basal forebrain cholinergic system.

  Behavioral neuroscience 20041201

• Effects of alpha-1 adrenergic receptor antagonist, terazosin, on cardiovascular functions in anaesthetised dogs.

  Indian journal of experimental biology 20041201

• Initial, long-term, and durable responses to terazosin, placebo, or other therapies for chronic prostatitis/chronic pelvic pain syndrome.

  Urology 20041101

• Sympathetic influence on capsaicin-evoked enhancement of dorsal root reflexes in rats.

  Journal of neurophysiology 20041001

• Baroreceptor mediated blood pressure regulation is not affected during dose dependent inhibition of prostatic contractions by terazosin.

  Indian journal of physiology and pharmacology 20041001

• Gross mapping of alpha1-adrenoceptors that regulate behavioral activation in the mouse brain.

  Behavioural brain research 20040709

• Meta-analysis: creating a level playing field for the patient with symptomatic benign prostatic hyperplasia?

  BJU international 20040701

• The role of alpha-blockers in the management of prostate cancer.

  Expert opinion on pharmacotherapy 20040601

• [The growth inhibition effect of alpha-adrenoceptor antagonists on androgen- independent prostate cancer cell line].

  Zhonghua wai ke za zhi [Chinese journal of surgery] 20040522

• Inhibition of human ether-a-go-go-related gene potassium channels by alpha 1-adrenoceptor antagonists prazosin, doxazosin, and terazosin.

  Naunyn-Schmiedeberg's archives of pharmacology 20040501

• Combination of finasteride and doxazosin for the treatment of benign prostatic hyperplasia.

  Expert opinion on pharmacotherapy 20040501

• Apoptotic impact of alpha1-blockers on prostate cancer growth: a myth or an inviting reality?

  The Prostate 20040401

• Measurement of low-dose active pharmaceutical ingredient in a pharmaceutical blend using frequency-domain photon migration.

  Journal of pharmaceutical sciences 20040301

• Regulatory considerations of pharmaceutical solid polymorphism in Abbreviated New Drug Applications (ANDAs).

  Advanced drug delivery reviews 20040223

• [Effect of nitric oxide donor and alpha1-receptor antagonist on proliferation/apoptosis of hyperplastic prostatic stromal cells in vitro].

  Zhonghua wai ke za zhi [Chinese journal of surgery] 20040222

• Herbal and vitamin supplement use in a prostate cancer screening population.

  Urology 20040201

• A current review of medical therapy for benign prostatic hyperplasia.

  The Journal of the American Osteopathic Association 20040201

• Validated specific HPLC methods for determination of prazosin, terazosin and doxazosin in the presence of degradation products formed under ICH-recommended stress conditions.

  Journal of pharmaceutical and biomedical analysis 20040127

• [Combined treatment of voiding disorders in women with m-cholinolytic and alpha 1-adrenoblocker].

  Urologiia (Moscow, Russia : 1999) 20040101

• Terazosin and doxazosin in the treatment of BPH: results of a randomized study with crossover in non-responders.

  Urologia internationalis 20040101

• Cost-effectiveness of tamsulosin, doxazosin, and terazosin in the treatment of benign prostatic hyperplasia.

  Journal of managed care pharmacy : JMCP 20040101

• The use and rationale of selective alpha blockade in children with non-neurogenic neurogenic bladder dysfunction.

  International braz j urol : official journal of the Brazilian Society of Urology 20040101

• A comparison of four different alpha1-blockers in benign prostatic hyperplasia patients with and without diabetes.

  Scandinavian journal of urology and nephrology 20040101

• Immobility from administration of the alpha1-adrenergic antagonist, terazosin, in the IVth ventricle in rats.

  Neuroscience letters 20031226

• Hormonal and morphologic evaluation of the effects of antiandrogens on the blood supply of the rat prostate.

  Urology 20031101

• Influence of hypertension on lower urinary tract symptoms in benign prostatic hyperplasia.

  International journal of urology : official journal of the Japanese Urological Association 20031101

• Growth inhibiting effects of terazosin on androgen-independent prostate cancer cell lines.

  Chinese medical journal 20031101

• [Pharmacologic treatment of benign prostatic hyperplasia].

  Orvosi hetilap 20030914

• The role of combination therapy for lower urinary tract symptoms secondary to benign prostatic hyperplasia.

  Current urology reports 20030801

• [Serum nitric oxide and D-dimer before and after administering antihypertensive drugs in essential hypertension].

  Hunan yi ke da xue xue bao = Hunan yike daxue xuebao = Bulletin of Hunan Medical University 20030801

• Role of epinephrine stimulation of CNS alpha1-adrenoceptors in motor activity in mice.

  Synapse (New York, N.Y.) 20030701

• Changes in nocturia from medical treatment of benign prostatic hyperplasia: secondary analysis of the Department of Veterans Affairs Cooperative Study Trial.

  The Journal of urology 20030701

• Effects of intravenous and infravesical administration of suramin, terazosin and BMY 7378 on bladder instability in conscious rats with bladder outlet obstruction.

  BJU international 20030701

• Doxazosin and terazosin suppress prostate growth by inducing apoptosis: clinical significance.

  The Journal of urology 20030401

• Anoikis induction by quinazoline based alpha 1-adrenoceptor antagonists in prostate cancer cells: antagonistic effect of bcl-2.

  The Journal of urology 20030301

• Effect of terazosin on clinical benign prostatic hyperplasia in older adults.

  Journal of the American Geriatrics Society 20030301

• Terazosin therapy for chronic prostatitis/chronic pelvic pain syndrome: a randomized, placebo controlled trial.

  The Journal of urology 20030201

• Identification of apoptotic and antiangiogenic activities of terazosin in human prostate cancer and endothelial cells.

  The Journal of urology 20030201

• Nitric oxide opposes glucose-induced hypertension by suppressing sympathetic activity.

  Hypertension (Dallas, Tex. : 1979) 20030201

• [Hepatotoxicity induced by terazosin].

  Medicina clinica 20030201

• Doxazosin induces apoptosis in cardiomyocytes cultured in vitro by a mechanism that is independent of alpha1-adrenergic blockade.

  Circulation 20030107

• [Results of treatment of irritative symptoms and urinary retention in patients 1 year after radical retropubic prostatectomy].

  Urologiia (Moscow, Russia : 1999) 20030101

• Plasma atrial natriuretic peptide in essential hypertension after treatment with terazocin.

  European journal of drug metabolism and pharmacokinetics 20030101

• The alpha1-adrenoceptor antagonist terazosin induces prostate cancer cell death through a p53 and Rb independent pathway.

  Oncology reports 20030101

• Comparison of finasteride and alpha-blockers as independent risk factors for erectile dysfunction.

  International journal of clinical practice 20030101

• Mice expressing the alpha(1B)-adrenergic receptor induces a synucleinopathy with excessive tyrosine nitration but decreased phosphorylation.

  Journal of neurochemistry 20021101

• Prophylactic versus therapeutic alpha-blockers after permanent prostate brachytherapy.

  Urology 20021001

• [Comparison of prazosin, terazosin and tramsulosin: functional and binding studies in isolated prostatic and vascular human tissues].

  Minerva urologica e nefrologica = The Italian journal of urology and nephrology 20020901

• [Effects of terazosine and atenolol on serum lipids in essential hypertension].

  Zeitschrift fur Kardiologie 20020901

• Prior iontophoresis of saline enhances vasoconstriction to phenylephrine and clonidine in the skin of the human forearm.

  British journal of clinical pharmacology 20020701

• Urodynamic effects of terazosin treatment for Japanese patients with symptomatic benign prostatic hyperplasia.

  The Journal of urology 20020601

• [Chiral separation and preparation of three new antagonists of alpha 1-adrenoceptors by chiral mobile phase HPLC].

  Yao xue xue bao = Acta pharmaceutica Sinica 20020601

• The efficacy of terazosin for treating benign prostatic hyperplasia: a multicentre clinical trial.

  BJU international 20020501

• Hypertension in L-NAME-treated diabetic rats depends on an intact sympathetic nervous system.

  American journal of physiology. Regulatory, integrative and comparative physiology 20020401

• Long-term risk of re-treatment of patients using alpha-blockers for lower urinary tract symptoms.

  The Journal of urology 20020401

• Role of supraspinal alpha1-adrenoceptors for voiding in conscious rats with and without bladder outlet obstruction.

  The Journal of urology 20020401

• Effect of fiduxosin, an antagonist selective for alpha(1A)- and alpha(1D)-adrenoceptors, on intraurethral and arterial pressure responses in conscious dogs.

  The Journal of pharmacology and experimental therapeutics 20020201

• Quinazoline-derived alpha1-adrenoceptor antagonists induce prostate cancer cell apoptosis via an alpha1-adrenoceptor-independent action.

  Cancer research 20020115

• Impact of alpha1-blockers in men with spinal cord injury and upper tract stasis.

  The journal of spinal cord medicine 20020101

• Alpha1-adrenoceptor antagonists radiosensitize prostate cancer cells via apoptosis induction.

  Anticancer research 20020101

• Apoptotic and proliferative index after Alpha-1-adrenoceptor antagonist and/or finasteride treatment in benign prostatic hyperplasia.

  Urologia internationalis 20020101

• [Treatment of external RF hyperthermia combining with alpha 1-adrenergic receptor blocker for patients with prostatodynia and chronic non-bacterial prostatitis].

  Zhonghua nan ke xue = National journal of andrology 20020101

• [Comparative evaluation of the efficacy of using terazosin and tamsulosin in patients with benign prostatic hyperplasia].

  Urologiia (Moscow, Russia : 1999) 20020101

• [Results of monotherapy with terazosin (kornam) in chronic infectious prostatitis patients].

  Urologiia (Moscow, Russia : 1999) 20020101

• [Use of alpha1-adrenergic blockaders in voiding disorders in women].

  Urologiia (Moscow, Russia : 1999) 20020101

• Terazosin for benign prostatic hyperplasia.

  The Cochrane database of systematic reviews 20020101

• Terazosin, doxazosin, and prazosin: current clinical experience.

  Urology 20011201

• 5alpha-reductase inhibitors: what role should they play?

  Urology 20011201

• Meta-analysis of randomized trials of terazosin in the treatment of benign prostatic hyperplasia.

  Urology 20011101

• Reduction of human prostate tumor vascularity by the alpha1-adrenoceptor antagonist terazosin.

  The Prostate 20010701

• Structure-activity studies for a novel series of bicyclic substituted hexahydrobenz[e]isoindole alpha1A adrenoceptor antagonists as potential agents for the symptomatic treatment of benign prostatic hyperplasia.

  Journal of medicinal chemistry 20010607

• Comparison of prazosin, terazosin and tamsulosin: functional and binding studies in isolated prostatic and vascular human tissues.

  The Prostate 20010601

• Pharmacological blockade of brain alpha1-adrenoceptors as measured by ex vivo [3H]prazosin binding is correlated with behavioral immobility.

  European journal of pharmacology 20010525

• Evaluating adverse cardiovascular effects of drug treatment for benign prostatic hyperplasia (BPH): methodological considerations.

  Journal of clinical epidemiology 20010501

• Initiation of nonselective alpha1-antagonist therapy and occurrence of hypotension-related adverse events among men with benign prostatic hyperplasia: a retrospective cohort study.

  Clinical therapeutics 20010501

• The short-term effects of terazosin in Japanese men with benign prostatic hyperplasia.

  Journal of Nippon Medical School = Nippon Ika Daigaku zasshi 20010401

• Overstimulation of the alpha1B-adrenergic receptor causes a 'seizure plus' syndrome.

  Nature medicine 20010201

• Magnetic resonance imaging and morphometric histologic analysis of prostate tissue composition in predicting the clinical outcome of terazosin therapy in benign prostatic hyperplasia.

  International journal of urology : official journal of the Japanese Urological Association 20010201

• [A randomized comparative study assessing once versus twice a day treatment of benign prostatic hyperplasia with terazosin].

  Hinyokika kiyo. Acta urologica Japonica 20010201

• alpha-Blockade improves symptoms suggestive of bladder outlet obstruction but fails to relieve it.

  The Journal of urology 20010101

• Targeted transurethral microwave thermotherapy versus alpha-blockade in benign prostatic hyperplasia: outcomes at 18 months.

  Urology 20010101

• Combined effect of terazosin and finasteride on apoptosis, cell proliferation, and transforming growth factor-beta expression in benign prostatic hyperplasia.

  The Prostate 20010101

• A quantitative analysis of antagonism and inverse agonism at wild-type and constitutively active hamster alpha1B-adrenoceptors.

  Naunyn-Schmiedeberg's archives of pharmacology 20010101

• [The efficacy and safety of terazosin and tamsulosin in patients with urinary disturbance accompanying prostatic hypertrophy].

  Hinyokika kiyo. Acta urologica Japonica 20010101

• Effect of terazosin on the lipid profile in patients with symptomatic benign prostatic hyperplasia.

  Urologia internationalis 20010101

• Efficacy and tolerability of drugs for treatment of benign prostatic hyperplasia.

  International urology and nephrology 20010101

• Use of terazosine in patients with chronic pelvic pain syndrome and evaluation by prostatitis symptom score index.

  International urology and nephrology 20010101

• High-performance liquid chromatographic analysis and pharmacokinetics of terazosin in healthy volunteers.

  Research communications in molecular pathology and pharmacology 20010101

• Suppression of human prostate cancer cell growth by alpha1-adrenoceptor antagonists doxazosin and terazosin via induction of apoptosis.

  Cancer research 20000815

• Alpha 1-adrenoceptor antagonists terazosin and doxazosin induce prostate apoptosis without affecting cell proliferation in patients with benign prostatic hyperplasia.

  The Journal of urology 19990601

• A meta-analysis on the efficacy and tolerability of alpha1-adrenoceptor antagonists in patients with lower urinary tract symptoms suggestive of benign prostatic obstruction.

  European urology 19990101

• Terazosin in benign prostatic hyperplasia: effects on blood pressure in normotensive and hypertensive men.

  British journal of urology 19980901

• Effects of oral and intravenous terazosin and head-up tilt on blood pressure responses in patients with hypertension.

  Journal of clinical pharmacology 19980601

• 4-Amino-2-[4-[1-(benzyloxycarbonyl)-2(S)- [[(1,1-dimethylethyl)amino]carbonyl]-piperazinyl]-6, 7-dimethoxyquinazoline (L-765,314): a potent and selective alpha1b adrenergic receptor antagonist.

  Journal of medicinal chemistry 19980409

• A double-blind comparison of terazosin and tamsulosin on their differential effects on ambulatory blood pressure and nocturnal orthostatic stress testing.

  European urology 19980101

• Clinical comparison of selective and non-selective alpha 1A-adrenoceptor antagonists for bladder outlet obstruction associated with benign prostatic hyperplasia: studies on tamsulosin and terazosin in Chinese patients. The Chinese Tamsulosin Study Group.

  Journal of medicine 19980101

• Synthesis and pharmacological characterization of 3-[2-((3aR,9bR)-cis-6-methoxy-2,3,3a,4,5,9b-hexahydro-1H-benz[e] isoindol-2-yl)ethyl]pyrido-[3',4':4,5]thieno[3,2-d]pyrimidine-2,4 (1H,3H)-dione (A-131701): a uroselective alpha 1A adrenoceptor antagonist for the symptomatic treatment of benign prostatic hyperplasia.

  Journal of medicinal chemistry 19970926

• Pharmacology of tamsulosin: saturation-binding isotherms and competition analysis using cloned alpha 1-adrenergic receptor subtypes.

  The Prostate 19970915

• Side effects of terazosin in the treatment of symptomatic benign prostatic hyperplasia.

  Southern medical journal 19970501

• Prostatic alpha 1-adrenoceptors and uroselectivity.

  The Prostate 19970215

• Coma from the health food store: interaction between kava and alprazolam.

  Annals of internal medicine 19961201

• A multicenter, randomized, double-blind, placebo-controlled study to evaluate the safety and efficacy of terazosin in the treatment of benign prostatic hyperplasia.

  Urology 19960301

• Use of recombinant alpha 1-adrenoceptors to characterize subtype selectivity of drugs for the treatment of prostatic hypertrophy.

  European journal of pharmacology 19950116

• Effect of alpha 1 adrenoceptor antagonists on prostatic pressure and blood pressure in the anesthetized dog.

  Urology 19940701

• Effects of ANG-converting enzyme and alpha 1-adrenoceptor inhibition on intrarenal hemodynamics in SHR.

  The American journal of physiology 19940501

• The alpha 1-adrenergic receptor that mediates smooth muscle contraction in human prostate has the pharmacological properties of the cloned human alpha 1c subtype.

  Molecular pharmacology 19940401

• [Use of terazosin and alfuzosin in the treatment of benign prostatic hypertrophy (BPH): our experience].

  Acta bio-medica de L'Ateneo parmense : organo della Societa di medicina e scienze naturali di Parma 19940101

• Intraoperative hypotension in a patient treated with terazosin, a new alpha-adrenergic receptor antagonist.

  Journal of clinical anesthesia 19940101

• [Comparison of selective alpha-1 blockades for alpha-receptors in human hypertrophied prostatic adenomas].

  Nihon Hinyokika Gakkai zasshi. The japanese journal of urology 19920301

• The efficacy and safety of terazosin for the treatment of symptomatic BPH.

  The Prostate 19910101